SARC scientific research committees have been established to work in collaboration overseeing our platforms and processes, facilitating the conduct of multi-institutional research, and supporting SARC’s primary mission – to identify new interventions for the prevention, diagnosis and treatment of sarcoma.

Listed below are three committees, along with a brief description, key responsibilities and the time commitment for each. You are welcome to nominate yourself, or others. Feel free to share this with any interested colleagues. 

Please send your nominations to SARC at sarc@sarctrials.org. If you want to be considered as a committee member, submit your CV/Biosketch as well.

Thank you very much for your consideration.

1. CLINICAL RESEARCH COMMITTEE:

The SARC Clinical Research Committee (CRC) will oversee the development of the clinical trial research platform for SARC and will actively seek to identify new opportunities for clinical research, assess scientific relevance and importance of proposed projects to move forth the science in sarcoma management, and seek new opportunities for collaboration within the SARC network.

KEY RESPONSIBILITIES:

• Provide medical representation at meetings with potential collaborators
• Determining priorities for subtype specific research
• Reviewing protocols and manuscripts

TIME COMMITMENT:

• The in-person Clinical Research Committee meeting is held annually in early June in Chicago, IL. It is held the Monday of ASCO
• The 4 conference calls are generally 1 hour in length and are held at the end of each quarter, alternating Monday’s and Wednesday’s

TERM LIMITS:

• Each term is 3 years with up to one additional consecutive term (maximum will be 6 consecutive years).

2. DEVELOPMENTAL THERAPEUTICS COMMITTEE:

The SARC Developmental Therapeutics Committee (DTC) will oversee the preclinical and laboratory research platform for SARC to identify new opportunities for clinical research.

KEY RESPONSIBILITIES:

• Assist SARC building a virtual portfolio of preclinical and translational services focused in sarcoma
• Prioritize agents based on therapeutic target, mechanism of action, areas of unmet clinical need, and potential for clinical development in SARC
• Provide scientific representation at meetings with potential collaborators

TIME COMMITMENT:

• An in-person meeting, when feasible, may be held jointly with the SARC Clinical Research Committee in early June in Chicago, IL. It is held the Monday of ASCO
• The 4 conference calls are generally 1 hour in length and are held quarterly on Friday’s

TERM LIMITS:

• Each term is 3 years with up to one additional consecutive term (maximum will be 6 consecutive years)

3. CONCEPT REVIEW COMMITTEE:

The SARC Concept Review Committee will provide in-depth scientific review of all new concepts submitted to SARC.

KEY RESPONSIBILITIES:

• Participate in peer review/discussion of concept scientific rationale
• Prepare and review literature as appropriate prior to concept review
• Review and evaluate new concepts submitted to SARC, review written feedback that will be provided to the investigator

TIME COMMITMENT:

• An in-person meeting, when feasible, may be held jointly with the SARC Clinical Research Committee in early June in Chicago, IL. It is held the Monday of ASCO
• The committee will meet on an as-needed basis, within 30 days of receipt of a new concept

TERM LIMITS:

• Each term is 3 years with up to one additional consecutive term (maximum will be 6 consecutive years